On October 16, 2020, Telcon RF Pharmaceutical Inc. (KOSDAQ:A200230) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
871 KRW | +4.56% | +7.00% | -0.23% |
1st Jan change | Capi. | |
---|---|---|
-0.23% | 72.35M | |
-4.34% | 196B | |
+35.99% | 100B | |
+69.18% | 70.38B | |
+17.03% | 61.11B | |
+32.24% | 32.65B | |
+17.50% | 21.52B | |
-2.90% | 19.01B | |
+51.01% | 18.57B | |
+7.74% | 17.67B |
- Stock Market
- Equities
- A200230 Stock
- News TELCON RF PHARMACEUTICAL. Inc.
- Telcon RF Pharmaceutical Inc. announced that it has received KRW 30 billion in funding from Emmaus Life Sciences, Inc.